Sasha King - Jun 7, 2021 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
Chief Marketing Officer
Signature
/s/ Peter Maag, as attorney-in-fact for Sasha King
Stock symbol
CDNA
Transactions as of
Jun 7, 2021
Transactions value $
-$564,023
Form type
4
Date filed
6/8/2021, 06:37 PM
Previous filing
Jun 4, 2021
Next filing
Jun 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Options Exercise $37.3K +3.05K +6.41% $12.24 50.6K Jun 7, 2021 Direct F1
transaction CDNA Common Stock Options Exercise $27.2K +1K +1.98% $27.17 51.6K Jun 7, 2021 Direct F1
transaction CDNA Common Stock Options Exercise $98K +4.02K +7.8% $24.35 55.6K Jun 7, 2021 Direct F1
transaction CDNA Common Stock Sale -$726K -8.07K -14.52% $90.01 47.5K Jun 7, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -3.05K -17.21% $0.00 14.7K Jun 7, 2021 Common Stock 3.05K $12.24 Direct F1, F3
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -1K -12% $0.00 7.33K Jun 7, 2021 Common Stock 1K $27.17 Direct F1, F4
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -4.02K -25.14% $0.00 12K Jun 7, 2021 Common Stock 4.02K $24.35 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.08, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F3 1/4th of the shares subject to the option vested on June 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
F4 1/4th of the shares subject to the option vested on February 4, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
F5 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter.